Concepedia

John Donaubauer

JD

2

Publications

692

Citations

2

H-Index

2000

Active since

Affiliations

AbbVie (United States)(Current)

John Donaubauer is an author at AbbVie (United States) specializing in drug discovery, medicine, and drug resistance.

Top concepts

MedicinePharmacologyDrug DiscoveryDrug ResistanceBiomolecular EngineeringHivImmunologyToxicologyEngineeringBiotechnology

Publications per year

2000–2021

2

Publications

2

Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development

Sanjay R. Chemburkar, John F. Bauer, Kris C. Deming et al. · Organic Process Research & Development · 2000 · 674 citations

Immunology, Pharmacotherapy, Antiviral Drug +17

Control of Mutagenic Impurities: Survey of Pharmaceutical Company Practices and a Proposed Framework for Industry Alignment

Christopher J. Borths, Mark D. Argentine, John Donaubauer et al. · Organic Process Research & Development · 2021 · 18 citations

Engineering, Purity Control, Pharmaceutical Company Practices +24

Rows per page

1–2 of 2